Skip to content

Clinical trials

Phase 1 Coronary Artery Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 1 Country / region: United States Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20051
20067
20074
20082
20095
20107
20111
20123
20131
20151
20161
20183
20191
20211
20222
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Terminated6
Withdrawn4
Unknown status3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic3
Vanderbilt University3
Washington University School of Medicine3
Bioheart, Inc.2
Eli Lilly and Company2
Fluoropharma, Inc.2
National Heart, Lung, and Blood Institute (NHLBI)2
TCA Cellular Therapy2
Thomas Jefferson University2
Arbutus Biopharma Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease48
Heart Diseases5
Myocardial Infarction5
Coronary Disease4
Heart Failure4
Cardiovascular Diseases3
Acute Coronary Syndrome2
Arteriosclerosis2
Atherosclerosis2
Diabetes Mellitus2

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.